Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
2
×
biotech
clinical trials
fda
life sciences
national blog main
abaloparatide
alprazolam
boston blog main
cgrp inhibitors
chronic migraine
colucid pharmaceuticals
drug enforcement administration
eli lilly
europe blog main
europe top stories
european commission
indiana
indiana blog main
indiana top stories
lasmiditan
migraine research foundation
national
osteoporosis
radius health
raleigh-durham blog main
raleigh-durham top stories
romosozumab
san francisco blog main
san francisco top stories
teriparatide
teva pharmaceutical
triptans
ucb
What
approval
2
×
drug
acute
addresses
amgen
amgen’s
carries
causes
condition
decades
developed
eli
europe
european
fda
friday
giant
giving
heart
lasmiditan
lilly
lilly’s
marketing
medication
medicine
migraine
new
nod
oks
osteoporosis
pharmaceutical
raise
risk
second
warning
wins
won
Language
unset
2
×
Current search:
amgen
×
approval
×
unset
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades